Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
The Long Run with Luke Timmerman
Timmerman Report
The Micah Hanks Program
Micah Hanks
TurfNet Podcasts
TurfNet RADIO
Blurry Creatures
Blurry Creatures
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
Pursuit of the Paranormal
Ash and Greg
Soundings
KVMR-FM
My Weird Prompts
Daniel Rosehill
The Observable Unknown
Dr. Juan Carlos Rey
Fox Weather Update
Fox Weather
Firing & Wiring
Interocept Labs
BlackBox - Psychologie der Extreme
Psychologinnen Maxi Diers und Barbara Focke
Veränderungskatalysator
Jasmin Schweiger
HAB gehört
Herzog August Bibliothek Wolfenbüttel
UEG Podcast
UEG United European Gastroenterology
You’re Probably Right
Murray Ed
No Lights Paranormal
No Lights Paranormal
Acid Horizon
Acid Horizon
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Podcast Agro Pintar
Choon Kiat Lim
CME in Minutes: Education in Oncology & Hematology
Answers in CME
Weathered Questions
Jan Ryherd & Kaj O'Mara
跨国串门儿计划
yikai
Unbuffered
Institute for Local Self-Reliance
The We Society
AcSS
Cose Molto Umane di Gianpiero Kesten
Gianpiero Kesten - Vois
TED-Ed
TED-Ed
Accidental Gods
Accidental Gods
Wildly Unplug
Lauren Connolly
Women Over 70: Aging Reimagined
Gail Zelitzky and Catherine Marienau
Aha! Zehn Minuten Alltags-Wissen
WELT
PBS Space Time
PBS
Almanacco del giorno
Streammo
Psychologically Speaking with Leila Ainge
Decibelle Creative
Darkwoodsparanormal
Darkwoods Paranormal
Reumatize
Reumatize
Unleashing Intuition Secrets
Michael Jaco
Science
Timmerman Report
Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.
Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.
Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to correct protein misfolding and mistrafficking at the root of many diseases.
Becky Pferdehirt, CEO of Emeryville, CA-based Radial, the life sciences unit of Astera Institute, on reimagining biology to take advantage of advances in AI.
Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."
Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.
Marty Burke, a professor of chemistry at the University of Illinois and co-founder of Excelsior Sciences, on making small molecule synthesis more automated for AI.
Abbas Kazimi, CEO of Boston-based Nimbus Therapeutics, on computation and culture for drug discovery.
Viswa Colluru, founder and CEO of Boulder, Colo.-based Enveda, on drug discovery with a chemistry platform inspired by natural products.
Otello Stampacchia, founder and managing director of Omega Funds, on attempting to reform Europe's biotech investment climate.
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.